Zhang Qin,Wang Han.Clinical study of bone marrow-sparing intensity-modulated radiation therapy for postoperative cervical cancer[J].Chinese Journal of Radiological Medicine and Protection,2015,35(6):441-444
Clinical study of bone marrow-sparing intensity-modulated radiation therapy for postoperative cervical cancer
Received:November 27, 2014  
DOI:10.3760/cma.j.issn.0254-5098.2015.06.009
KeyWords:Cervical cancer  Bone marrow-sparing  Intensity-modulated radiation therapy  Toxicity reaction
FundProject:
Author NameAffiliation
Zhang Qin Deparment of Oncology, the First People's Hospital of Jining, Jining 272100, China 
Wang Han Deparment of Oncology, the First People's Hospital of Jining, Jining 272100, China 
Hits: 3356
Download times: 2567
Abstract::
      Objective To observe the therapeutic effects and toxicities of bone marrow-sparing intensity-modulated radiation therapy(BMS-IMRT) for postoperative cervical cancer. Methods From January 2011 to June 2012, totally 70 postoperative patients with cervical cancer were divided into BMS-IMRT group with 34 cases and IMRT group with 36 cases randomly. External whole pelvic intensity-modulated irradiation combined with chemotherapy was carried out for all patients. The planning target volume received a dose of 45 Gy/25 fractions in all patients. Delineation of the pelvis and limitation dose were carried out in BMS-IMRT group: the pelvis V30≤50%. All cases received chemotherapy with cisplatin (40 mg/m2) once a week concurrently with radiotherapy. Results Treatment was completed in 67 patients, as the other 3 patients stopped chemotherapy because of myelosuppression. There was no statistically significant differences between two groups for the 2-year local control survival(LCS)and overall survival(OS), alimentary tract toxicity and urinary toxicity. IMRT group had more serious hematologic toxicity than BMS-IMRT group, with statistically significant difference (χ2=14.355, P<0.05). Conclusions The postoperative cervical cancer patients with poor prognostic factors who undergo concurrent chemoradiotherapy, IMRT group has more serious hematologic toxicity than BMS-IMRT group. The short-term effect and other toxicities reaction are similar between two groups.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9080371  On-line:0

v
Scan QR Code
&et=3C06DB566315F8DC59AE367DE863DD0BAF414F416B602E3FF854EEE816E3A0560116BF3AAEFB177B3D69F25808CD08DD737AEDF4CE6997D20595328BCF811E9060CE36DC22F88D8DBA18E0F618E78BB422D391EB2B51C96DCBD38F7F0064B88727FDF7B58280D47F61BDBFB1277F9849&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FFD10F7019FAA9EC&aid=5F7737E5A04D36C7A1B9D1DB84C513C5&vid=&iid=B31275AF3241DB2D&sid=5319469C819FCFF1&eid=68FDAD96FCC0AB1B&fileno=20150609&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FFD10F7019FAA9EC"; var my_aid="5F7737E5A04D36C7A1B9D1DB84C513C5";